The Carlyle Group
http://www.carlyle.com/The Carlyle Group is one of the world’s largest private equity firms. The firm has more than $81.1 billion under management with 60 funds across four investment disciplines: buyouts, venture & growth capital, real estate and leveraged finance. Carlyle focuses on sectors including: aerospace & defense, automotive & transportation, consumer & retail, energy & power, financial services, healthcare, industrial, infrastructure, real estate, technology & business services and telecommunications & media. Carlyle employs more than 575 investment professionals, and its portfolio companies employ more than 286,000 people worldwide. The firm is based in Washington DC and has over 1200 investors in 68 countries.
View Older Stories
-
U.S. Physical Therapy names Nchacha Etta as CFO, effective Sept. 2026
-
Form SCHEDULE 13G/A SunPower Inc. Filed by: Carlyle Group Inc.
-
Form S-8 Carlyle Group Inc.
-
Form 10-Q Carlyle Group Inc. For: Jun 30
-
Form 13F-HR Carlyle Group Inc. For: Jun 30
-
Ashland said to explore sale amid takeover interest - Bloomberg
-
Carlyle takes minority stake in Prime Capital Financial at $1.8B value
-
Carlyle sees improving exit conditions for "good companies"
-
The Carlyle Group (CG) Tops Q2 EPS by 13c
-
Form 8-K Carlyle Group Inc. For: Aug 05
-
Form 4 Carlyle Group Inc. For: Aug 01 Filed by: Andrews Charles Elliott Jr.
-
Form 4 Carlyle Group Inc. For: Aug 01 Filed by: Plouffe Justin
-
Form 4 Carlyle Group Inc. For: Aug 01 Filed by: Redett John C.
-
Form 4 Carlyle Group Inc. For: Aug 01 Filed by: Heinzelman Kate Elizabeth
-
Form 4 Carlyle Group Inc. For: Aug 01 Filed by: Nedelman Jeffrey
-
Form 4 Carlyle Group Inc. For: Aug 01 Filed by: LoBue Lindsay
-
Form 4 Carlyle Group Inc. For: Aug 01 Filed by: Jenkins Mark David
-
Bloomberg to acquire private markets data firm Canoe Intelligence
-
Haemonetics adds Martin Madaus to its board of directors
-
Form SCHEDULE 13G/A Carlyle Group Inc. Filed by: BlackRock, Inc.
-
The Carlyle Group LP (CG) PT Lowered to $70 at Citizens: Group Down Roughly 29% YTD
-
Form 3 Carlyle Group Inc. For: Jun 29 Filed by: Heinzelman Kate Elizabeth
-
Form SCHEDULE 13G/A Q32 Bio Inc. Filed by: Carlyle Group Inc.
-
KBR names CEO and CFO for planned MTS spin-off company
-
Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says
-
Carlyle and Content Partners close film and TV continuation vehicle
-
Syntiant adds two directors to board
-
Carlyle completes majority stake acquisition in MAI Capital Management
-
Form 8-K Carlyle Group Inc. For: Jun 03
-
Form 8-K Carlyle Group Inc. For: Jun 01
-
Form 4 Carlyle Group Inc. For: May 28 Filed by: LoBue Lindsay
-
Form 4 Carlyle Group Inc. For: May 28 Filed by: Plouffe Justin
-
Form 4 Carlyle Group Inc. For: May 28 Filed by: Jenkins Mark David
-
Form 4 Carlyle Group Inc. For: May 28 Filed by: Andrews Charles Elliott Jr.
-
Form 4 Carlyle Group Inc. For: May 28 Filed by: Nedelman Jeffrey
-
Form 4 Carlyle Group Inc. For: May 28 Filed by: Ferguson Jeffrey W.
-
Form 4 Carlyle Group Inc. For: May 28 Filed by: Redett John C.
-
Form 4 Carlyle Group Inc. For: May 28 Filed by: SCHWARTZ HARVEY M
-
Conduent names Adam Demuyakor to board of directors
-
AB, Brookfield, Carlyle launch private markets solution for 401k plans
-
Form SCHEDULE 13G/A StandardAero, Inc. Filed by: Carlyle Group Inc.
-
Form SCHEDULE 13G/A Medline Inc. Filed by: Carlyle Group Inc.
-
Form SCHEDULE 13G/A Carlyle Group Inc. Filed by: Capital World Investors
-
RBC Capital Downgrades The Carlyle Group LP (CG) to Sector Perform
-
Form 13F-HR Carlyle Group Inc. For: Mar 31
-
Form S-3ASR Carlyle Group Inc.
-
Form 10-Q Carlyle Group Inc. For: Mar 31
-
CFRA Downgrades The Carlyle Group LP (CG) to Sell
-
TD Cowen Downgrades The Carlyle Group LP (CG) to Hold
-
The Carlyle Group (CG) Misses Q1 EPS by 11c

